Sign In
Buy CZMWY
$30.31
+0.0800 (+0.265%)
At Close: Jun 03, 2026
Carl Zeiss Meditec AG (CZMWY) Q2 2026 Earnings Call Transcript
10:40pm, Wednesday, 13'th May 2026
Carl Zeiss Meditec AG (CZMWY) Q2 2026 Earnings Call Transcript
Carl Zeiss Meditec Q2 Earnings Call Highlights
06:10am, Tuesday, 12'th May 2026
Carl Zeiss Meditec ETR: AFX reported weaker first-half results for fiscal 2025/2026 and outlined a broad restructuring plan aimed at restoring profitability over the next three years, as management po
Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Large Increase in Short Interest
02:20am, Monday, 27'th Apr 2026
Carl Zeiss Meditec AG (OTCMKTS:CZMWY - Get Free Report) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totaling 5,102 shares, a growth of 89
Carl Zeiss Meditec: Bad Optics But With 'Buy' Potential
05:42pm, Tuesday, 21'st Apr 2026
Carl Zeiss Meditec AG is rated a "Buy" despite recent operational weakness and geopolitical headwinds, especially in Asia-Pacific and North America. Sales declined 4.8% in Q1, with margin compression
Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Receives Average Recommendation of “Hold” from Analysts
01:17am, Friday, 20'th Mar 2026
Shares of Carl Zeiss Meditec AG (OTCMKTS:CZMWY - Get Free Report) have been assigned a consensus rating of "Hold" from the six ratings firms that are covering the stock, MarketBeat.com reports. One re
Carl Zeiss Meditec AG (CZMWY) Q1 2026 Earnings Call Transcript
09:27pm, Friday, 13'th Feb 2026
Carl Zeiss Meditec AG (CZMWY) Q1 2026 Earnings Call Transcript
Carl Zeiss Meditec: Why This Company Is A Good Choice For 2026
01:30pm, Thursday, 15'th Jan 2026
Carl Zeiss Meditec is rated a 'Strong Buy' with higher share price target, reflecting significant undervaluation and robust fundamentals. The company achieved over €2.2B in revenue (+7.5% YoY), stro
Carl Zeiss Meditec AG (CZMWY) Q4 2025 Earnings Call Transcript
03:49pm, Monday, 15'th Dec 2025
Carl Zeiss Meditec AG (CZMWY) Q4 2025 Earnings Call Transcript
Carl Zeiss Meditec AG (CZMWY) Discusses CEO Transition and Management Continuity Strategy Following Code of Conduct Investigation Transcript
Carl Zeiss: The Results After 6M25 Are Encouraging For 2025-2027E
03:25am, Sunday, 08'th Jun 2025
Carl Zeiss Meditec remains a high-quality medtech leader with strong moats in ophthalmic and microsurgery, despite recent margin pressures and Chinese market headwinds. Recent 6M25 results show encour
Carl Zeiss Meditec AG (CZMWF) Q2 2025 Earnings Call Transcript
10:59pm, Friday, 16'th May 2025
Carl Zeiss Meditec AG (OTCPK:CZMWF) Q2 2025 Earnings Conference Call May 13, 2025 4:30 AM ET Company Participants Sebastian Frericks - Director of Investor Relations Markus Weber - President and Chief
Carl Zeiss Meditec: Recovery Seems Clear Enough
01:41am, Sunday, 09'th Mar 2025
Carl Zeiss Meditec remains a "Buy" despite tariff concerns, with a revised price target of €110/share, reflecting geopolitical uncertainties and potential impacts on US-based revenues. The company s
Carl Zeiss: Why I Am So Positive
03:01am, Wednesday, 04'th Dec 2024
Carl Zeiss Meditec is a high-quality MedTech company with a strong market position, low debt, and significant long-term upside potential despite current macroeconomic challenges. The company's fundame
My 3 Favorite European Stocks To Diversify Your Portfolio
07:00am, Sunday, 29'th Sep 2024
Here is an emphasis on the importance of diversification in US-based investment portfolios to mitigate risks and enhance returns. The recommendation is to focus on sectors with strong growth potential
Carl Zeiss: Significant Underperformance, Valuation At Multi-Year Lows
03:35am, Monday, 09'th Sep 2024
Carl Zeiss Meditec has seen a 30%+ decline due to earnings and margin drops, but remains a strong market leader with significant long-term upside. Despite current underperformance, the company's strat
